Therapeutic Solutions International (TSOI) Stock Statistics & Valuation Metrics
Total Valuation
Therapeutic Solutions International has a market cap or net worth of $7,049.00. The enterprise value is $1.37T.
- Market Cap
- $7,049.00
- Enterprise Value
- $1.37T
Share Statistics
Therapeutic Solutions International has 7,049,488,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 7,049,488,000
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Therapeutic Solutions International’s return on equity (ROE) is -1.93 and return on invested capital (ROIC) is -91.55%.
- Return on Equity (ROE)
- -1.93
- Return on Assets (ROA)
- -0.66
- Return on Invested Capital (ROIC)
- -91.55%
- Return on Capital Employed (ROCE)
- -1.43
- Revenue Per Employee
- 33.00K
- Profits Per Employee
- -723.27K
- Employee Count
- 3
- Asset Turnover
- 0.03
- Inventory Turnover
- 1.63
Valuation Ratios
The current PE Ratio of Therapeutic Solutions International is -0.01. Therapeutic Solutions International’s PEG ratio is -0.00.
- PE Ratio
- -0.01
- PS Ratio
- 0.52
- PB Ratio
- 0.03
- Price to FCF
- -0.05
- Price to Operating Cash Flow
- -0.03
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Therapeutic Solutions International had revenue of 98.99K and earned -2.17M in profits. Earnings per share was -0.00.
- Revenue
- 98.99K
- Gross Profit
- 62.23K
- Operating Income
- -1.99M
- Pretax Income
- -2.22M
- Net Income
- -2.17M
- EBITDA
- -1.49M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -484.11K and capital expenditures -16.14M, giving a free cash flow of -16.63M billion.
- Operating Cash Flow
- -484.11K
- Free Cash Flow
- -16.63M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Therapeutic Solutions International pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2091.57%
- Earnings Yield
- -6847.21%
Stock Price Statistics
- Beta
- 2.09
- 52-Week Price Change
- -99.24%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Therapeutic Solutions International as a current ratio of 0.05, with Debt / Equity ratio of 78.92%
- Current Ratio
- 0.05
- Quick Ratio
- 0.03
- Debt to Market Cap
- 0.24
- Net Debt to EBITDA
- -0.58
- Interest Coverage Ratio
- -4.69
Taxes
In the past 12 months, Therapeutic Solutions International has paid 2,250 in taxes.
- Income Tax
- 2,250
- Effective Tax Rate
- -0.00
Enterprise Valuation
Therapeutic Solutions International EV to EBITDA ratio is -0.61, with an EV/FCF ratio of -0.85.
- EV to Sales
- 9.21
- EV to EBITDA
- -0.61
- EV to Free Cash Flow
- -0.85
- EV to Operating Cash Flow
- -0.86
Balance Sheet
Therapeutic Solutions International has $9,233.00 in cash and marketable securities with $929.63K in debt, giving a net cash position of -$920.39K billion.
- Cash & Marketable Securities
- $9,233.00
- Total Debt
- $929.63K
- Net Cash
- -$920.39K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 62.86%, with operating margin of -2006.67%, and net profit margin of -2191.86%.
- Gross Margin
- 62.86%
- Operating Margin
- -2006.67%
- Pretax Margin
- -2245.04%
- Net Profit Margin
- -2191.86%
- EBITDA Margin
- -1502.53%
- EBIT Margin
- -1817.47%
Analyst Forecast
The average price target for Therapeutic Solutions International is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
